The impact of insulin sensitivity, casual blood pressure and 24-h ambulatory blood pressure on endothelial function was studied in treated hypertensive subjects. Flow-mediated dilatation of the brachial artery after reperfusion was used to determine endothelial function. Insulin sensitivity indices were obtained by using the homeostasis model assessment, after 75 g Dextrose oral glucose tolerance tests (Matsuda index) and the euglycemic hyperinsulinemic clamp (M-value) in 49 patients with arterial hypertension. The insulin sensitivity indices were compared with healthy controls matched for body weight, age and sex (n ¼ 23). Hypertensive patients under therapy were insulin resistant, had higher LDL-cholesterol levels, higher blood pressure and lower endothelial function than healthy controls. Flow-mediated dilatation showed, in the study population being treated for arterial hypertension, no relationships of all insulin sensitivity indices with flow-mediated dilatation, casual blood pressure in the morning before the tests and 24-h ambulatory blood pressure. Flow-mediated dilatation was strongly influenced by nocturnal systolic and diastolic 24-h ambulatory blood pressure (systolic: R 2 ¼ 0.0943, Po0.05; diastolic: R 2 ¼ 0.0947, Po0.05). Therefore, endothelial function in these patients is predominantly influenced by nocturnal systolic and diastolic blood pressure and not by insulin sensitivity.
Introduction
Insulin resistance (IR) and hyperinsulinemia are frequently found in subjects with arterial hypertension when compared with normotensive control subjects matched for age and weight. [1] [2] [3] Insulin, independent of its effects on blood pressure and plasma lipids, is known to be atherogenic. The hormone enhances cholesterol transport into arteriolar smooth muscle cells and increases endogenous lipid synthesis by these cells. Insulin also stimulates the proliferation of arteriolar smooth muscle cells, augments collagen synthesis in the vascular wall, increases the formation and decreases the regression of lipid plaques, and stimulates the production of various growth factors. 4, 5 IR alters the expression of vasoactive mediators and has a function in the impairment of the dilatatory capacity of the endothelium, that is endothelial function. 6 A dysfunctioning endothelium may lose its ability to exert its protective effects on the vascular system because of a reduction in its anti-atherosclerotic and anti-thrombotic actions and thus is a key factor in the development of the atherosclerotic process. 7 Several techniques have been used to measure endothelial dysfunction under various clinical conditions. The flow-mediated arterial dilatation (FMD) in the brachial artery is a non-invasive technique to test the integrity of endothelial function. [8] [9] [10] Shear stress is considered to be the primary mechanical stimulus in FMD. 11 Several mediators are thought to be involved in FMD, for example prostaglandins, an endothelium-derived hyperpolarizing factor and most importantly nitric oxide (NO). 8 Forearm endothelial dysfunction is a marker for predicting cardiovascular events in patients with essential hypertension 12 and predicts the outcome even in patients with coronary artery disease. 13 The most common approach to treat hypertension is through the use of anti-hypertensive drugs rather than with a reduction in body weight 14 or treatment of IR. 15, 16 Numerous studies have shown that certain classes of anti-hypertensive agents have differential effects on carbohydrate and lipid metabolism in humans. In general, high doses of thiazide diuretics (that is X25 mg per day hydrochlorothiazide) and bblockers, at all dose levels, worsen glycemic control and b-blockers worsen insulin sensitivity. On the other hand, ACE inhibitors, angiotensin II receptor blockers and calcium channel blockers (CCBs) have neutral or beneficial effects on these variables. 17 The main issue of this study in hypertensive patients was to evaluate the influence of insulin sensitivity and blood pressure control on endothelial function considered as a prognostic risk factor for future cardiovascular diseases. 12 
Patients and methods
A total of 49 patients with arterial hypertension of a study published recently 15, 18 were compared with 23 healthy subjects matched for age, weight and gender obtained from the EU-RISC study. 19, 20 Only hypertensive patients without nicotine consumption and concomitant cardiovascular diseases, that is without retinopathy, negative microalbuminuria and with normal left ventricular function and ventricle size, were selected. Inclusion criteria for the healthy control group were non-smoker, negative family history for diabetes mellitus and cardiovascular diseases, negative microalbuminuria, no metabolic disorder and therapy with fibrates or cholesterol lowering drugs. Exclusion criteria were diabetes mellitus, impaired fasting glucose tolerance and impaired glucose tolerance according to the criteria of the American Diabetes Association. All participants undergoing the metabolic tests were asked to fast from 2000 hours the previous evening with only calorie-free, caffeine-free beverages (water) to be taken. Subjects should not come to the clinic by bicycle and should refrain from heavy or unusual physical exercise for 2 days before each test.
Assessment of insulin sensitivity indices (SI): HOMA, Matsuda index, M-value Several methods are available for the measurement of SI in humans. These include the evaluation of fasting glucose and insulin ratio, the analysis of glucose and insulin profiles after oral glucose load using 75 g dextrose (OGTT) and the so-called 'gold standard' method, which is the euglycemic hyperinsulinemic clamp technique. 21, 22 Three indices were obtained using different procedures: (1) homeostasis model assessment (HOMA 23 ): fasting glucose (mmol l -1 ) Â fasting insulin (mU l -1 ); (2) Matsuda index of glucose and insulin profiles after OGTT: 24 10 000 OG0 Â I0x G mean Â I mean , where G and I represent the plasma glucose (mg per 100 ml) and insulin (mU l -1 ) concentrations, respectively, expressing fasting (0) and mean OGTT concentrations; (3) euglycemic, hyperinsulinemic clamp technique (M-value) as described recently in the EU-RISC protocol: 19, 25 Exogenous insulin is administered as a primed-continuous infusion at a rate sufficient to maintain a pre-set hyperinsulinemic plateau; simultaneously, the glucose concentration is clamped at the normal fasting level by means of an exogenous infusion of glucose. With this latter technique, the insulin action is measured in vivo under comparable conditions of stimulus (the plasma insulin concentration) and substrate (the plasma glucose concentration 26 ). When a steady state is attained, the exogenous glucose infusion rate equals the amount of glucose disposed of by all the tissues in the body and thus provides a quantification of overall insulin sensitivity (Mvalue). The M-value of this study was the mean glucose infusion rate between 80 and 120 min. In practice, insulin was infused at 1 mM min -1 kg -1 (7 pmol min -1 kg -1 ) for 2 h via a cannula in an antecubital vein. Glucose was infused via a second antecubital vein cannula and was adjusted every 5-10 min to maintain plasma glucose within 10% of the baseline value. Blood samples were obtained from a wrist vein heating the hand to 60 1C on a heating pad (for intermittent blood sampling of arterialized venous blood), for measurement of plasma and insulin concentrations. 25 
Flow-mediated vasodilatation (FMD)
The flow-mediated vasodilatation was performed according to a slightly modified protocol described elsewhere. 9, 10, 27 In brief, the measurements were carried out using the sonography device Esaote Biomedica Megas. The brachial artery was scanned in a longitudinal section 2-15 cm above the elbow, and the area of the artery that provided the clearest picture of the anterior and posterior walls was identified. The skin was marked in the most satisfactory transducer position found to assure that, for all measurements throughout the study, the same transducer position was used.
Flow-mediated dilatation. After baseline measurement of the flow velocity and the diameter of the brachial artery, a pneumatic tourniquet was placed around the forearm and inflated to a pressure of about 200-250 mm Hg (at least 30 mm Hg above SBP). The pressure was maintained for 4.5 min. Flow velocity was measured before and for the first 15 s after release of the cuff. The diameter of the brachial artery and the flow velocity were measured 1, 2, 3, 5, 10 and 15 min after cuff deflation.
Nitroglycerin (GTN)-mediated dilatation.
A period of about 30 min after cuff deflation was allowed for recovery before the baseline measurement for the nitroglycerin test. Two observers, blinded to the interventions, performed all measurements. Reproducibility was assessed in 10 individuals (10 men; age 53 ± 11.5 years) who were examined twice Nocturnal blood pressure regulates endothelial function T Konrad et al at 2-week intervals. The intraobserver intersession coefficients of variation ((s.d. of the difference/_2)/ pooled mean) were distensibility coefficients 11.9% (brachial); compliance coefficients 12.1% (brachial) and endothelium-dependent and -independent dilatation, expressed as absolute diameter, 13.7 and 11.3%, respectively. 10 Blood pressure measurements Blood pressure was monitored using a sphygmomanometer (Omron 705CP) after sitting for at least 10 min during clinic visits, taking the mean of the second and third of three consecutive measurements (casual blood pressure, RRc). Ambulatory blood pressure over 24 h (24RR) was registered with Mobil-O-Graph (i.e.m., Stolberg, Germany). Monitoring began at B1000 hours, and blood pressure was measured every 15 min during the daytime, and 30 min during the night. From these data, average daytime (1000-2200 hours) and night time (1100-2000 hours) systolic and diastolic levels were calculated. Normal blood pressure was defined as o140/85 mm Hg for the measurements during the day, and o125/80 mm Hg for the night, respectively. Patients with a nocturnal fall of systolic and diastolic blood pressure of 415% were defined as dippers. 28 Statistical methods. All calculations and statistical analysis were performed with SigmaStat for Windows 3.0.1 Fa. SPSS Inc. Comparison between groups was done with the two-sided, unpaired t-test when the parameters were normally distributed, otherwise the Mann-Whitney rank sum test was used. All data were presented as mean±s.d. The Pearson product-moment correlation coefficient was used to measure the correlation between the two variables.
Ethics.
The study protocol was approved by the Ethics Committees of the Johann Wolfgang GoetheUniversity, Frankfurt and the Medical Chamber of Hassia. All patients gave written informed consent. The trial was carried out in accordance with the laws and guidelines valid at that time, that is, the German drug law, the principles of the Declaration of Helsinki, and the European Note for Guidance for Good Clinical Practice.
Results
Demographic data, SI Indices and blood pressure Hypertensive subjects with a history of hypertension of about 10 years were compared with healthy control subjects matched for body weight, age and sex (controls: females n ¼ 10, males n ¼ 13; hypertensive patients: females n ¼ 20, males n ¼ 29; Table 1 ). The body mass indices of both groups were in the overweight range according to WHO classification. Patients with high blood pressure were maintained on various anti-hypertensive regimens (Table 1) . Selective b-blockers were used. Abbreviations: ACE, angiotensin converting enzyme; ALA, alanine aminotransferase activity; AST, aspartate aminotransferase activity; AT1, angiotensin 1 receptor; BMI, body mass index; CCB, calcium channel blocker; FMD, flow-mediated arterial dilatation; gGT, g-glutamyltransferase activity; GTN, glyceryl trinitrate; HDL, HDL-cholesterol; HF, heart frequency; HOMA, homeostasis model assessment; HTZ, hydrochlorothiazide; LDL, LDL-cholesterol; R-DM, diamter in the resting state; RRdia, diastolic blood pressure; RRsys, systoloc blood pressure; TGL, triglyzerides. Medical treatment of hypertensives: none medication n ¼ 9, ACE or AT1-blocker n ¼ 13, two medications (ACE or AT1-blocker and CCBs or b-blocker) n ¼ 7/4, triple therapy (ACE or AT1-blocker, CCBs or b-blocker and hydrochlorothiazide 12.5 mg (HTZ)) n ¼ 6/5, and four medications (ACE or AT1-blocker, CCBs, b-blocker and HTZ) n ¼ 5.
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The blood pressure of the treated groups did not differ significantly (ranges: 133 ± 14 mm Hg (no medication) to 143±22 mm Hg (four medications). The blood pressure obtained after treatment could be classified (ESC criteria 29 ) as 'high normal'; the cardiovascular risk profile was at 'low added risk' (1-2 additional risk factors). The blood pressure measurements in the morning as well as over 24 h were not related to treatment and did not differ between the therapy regimens. The casual blood pressure was significantly higher in the group with arterial hypertension than in controls.
Although fasting glucose concentrations did not differ between controls and subjects with high blood pressure, fasting insulin concentrations were more than twofold higher in hypertensive subjects. Correspondingly, the higher HOMA index reflects a significant decrease in SI in hypertensive subjects in the fasting state. The analysis of glucose and insulin profiles after OGTT, as described by Matsuda and DeFronzo, 24 revealed a nearly 50% reduced SI. Peripheral glucose uptake measured by the clamp technique was about 30% lower than in control subjects. LDL-cholesterol concentrations tended to be higher in hypertensive patients than in controls (P ¼ 0.08). Liver enzyme concentrations were in the normal range in both groups, but significantly higher in hypertensive patients (Table 1) .
Endothelial function, measured as flow-mediated vasodilatation of the arteria brachialis was significantly influenced by fasting glucose (r ¼ À0.274, P ¼ 0.06), resting diameter (r ¼ À0.251, P ¼ 0.08) and insulin sensitivity (Matsuda index r ¼ 0.346, P ¼ 0.02) in the healthy control group. Body weight, heart rate frequency and total cholesterol tended to have a negative influence on FMD in patients with high blood pressure (P ¼ 0.08 for all variables). None of the insulin sensitivity parameters was related to endothelial function in hypertensive patients. The numerous studies have shown that certain classes of anti-hypertensive agents have differential effects on carbohydrate and lipid metabolism in humans. In general, high doses of thiazide diuretics (that is X25 mg per day hydrochlorothiazide) and b-blockers, at all dose levels, worsen glycemic control and b-blockers worsen insulin sensitivity. On the other hand, ACE inhibitors, angiotensin II receptor blockers and CCBs have neutral or beneficial effects on these variables. 17 Various therapy regimens showed no significant effects on SI indices. Casual blood pressure had no effect on FMD in the two groups. Twenty-four hours blood pressure as well as diurnal blood pressure showed no effects on FMD (Figure 1) . Nocturnal blood pressure influenced strongly the endothelial-dependent vasodilatation in hypertensive patients (Figure 2 ). Endothelial-independent vasodilatation using GTN was closely related with 24 h blood pressure (Po0.05), nocturnal systolic and diastolic blood pressure (Po0.01).
Discussion
This study in patients being treated for high blood pressure yielded evidence that blood pressure regulation and endothelial function are not related to IR as assessed by different indices of SI. The most important factor influencing endothelial function in hypertensive subjects was nocturnal systolic and diastolic blood pressure (Figure 2) . The various antihypertensive therapy regimens had no influence on insulin sensitivity in the patients. 
Nocturnal blood pressure regulates endothelial function T Konrad et al
This study confirms the recently published findings 3 that glucose homeostasis is impaired in hypertensive patients. IR is a metabolic perturbation and seems to be related to endothelial dysfunction in normotensive offspring of subjects with arterial hypertension as well as in hypertensive patients. 30 Lurbe et al. 31 found a strong relationship between IR, determined by HOMA and increased nocturnal blood pressure in a large cohort of obese children. Both, IR and elevated nocturnal blood pressure seem to be predictive of renal disease and cardiometabolic syndrome. 32, 33 In contrast to these studies in which IR was determined by measurement of fasting insulin concentrations or HOMA, this study used a variety of methods to determine insulin sensitivity in the studied groups: HOMA using fasting insulin and glucose as parameters reflects predominantly hepatic insulin sensitivity, 34 the oral glucose load is an index of the glucose metabolism of the whole body, that is glucose uptake by the liver, muscles and adipose tissue, 35 and the clamp technique measures peripheral glucose uptake of muscle tissue at steady state insulin concentrations. 26 A state of cellular resistance to the action of insulin can be assumed to occur in the observed hyperinsulinism. Using the insulin/glucose-clamp technique in combination with an infusion of tracer glucose and indirect calorimetry, it has been shown that the IR in patients with essential hypertension is located in peripheral tissues (muscle), is limited to non-oxidative pathways of glucose metabolism (glycogen synthesis), and is directly correlated with the severity of hypertension. Attempts were often made to associate IR in essential hypertension with in at least four general types of mechanisms: Na þ retention, overactivity of sympathetic nervous system, disturbed membrane ion transport and proliferation of vascular smooth muscle cells. 1, 14, 36 However, this study in hypertensive patients with a low cardiovascular risk profile reveals that these mechanisms have no direct impact on endothelium-derived vasodilatation or on non-endothelium-dependent vasodilatation after GTN application. The weak relationship between FMD and SI found in our healthy control group confirms that endothelial function and insulin sensitivity are positively correlated in healthy humans. 37 Thus, if other risk factors are present, our study puts IR as a 'primum movens' 36 for vascular diseases into question. The result of two studies in which IR in hypertensive patients was treated by pioglitazone are of interest in this regard: insulin sensitivity improved and blood pressure fall 15 but endothelial dysfunction and ambulatory 24 h blood pressure remained unchanged. 34, 36 Blood pressure exhibits a natural circadian rhythm characterized by a decrease during sleep, and a steep increase in the early morning period followed by higher values throughout the active waking period. In our study, however, it was the nocturnal blood pressure that has the most marked effect on endothelial-derived vasodilatation in hypertensive patients (Figure 2 ). When the blood pressure was near normal by using anti-hypertensive drug therapy, the nocturnal blood pressure was the major factor influencing the endothelial function in these patients. The blunted fall in blood pressure during the night, that is dipping, seems to reduce oxidative stress in hypertensive patients when compared with non-dippers. A non-dipping nocturnal BP is associated with elevated levels of substances associated with endothelial dysfunction, that is D-dimer and the von Willebrand factor. 38 Endothelium-dependent vasodilatation is blunted through a decrease in NO release in non-dippers when compared with patients who have dipper hypertension. 39, 40 In hypertensive subjects, reduced FMD, that is endothelial dysfunction, is due to a lower arterial shear stress: there is linear relationship between peak systolic shear stress and the resulting percent change in diameter from baseline. 11 If endothelial dysfunction persists, compliance of the central vasculature system decreases and this is followed by increased arterial stiffness. 41 Arterial stiffness is related to vascular inflammation as assessed by C-reactive protein, interleukin-6 and tumour necrosis factor-a. This endothelial inflammation is enhanced by arterial hypertension 42 and IR. 43 Endothelial dysfunction in the brachial artery in patients with essential hypertension is not improved by acute blood pressure reduction. 44 Therefore, a long-term well-controlled blood pressure may be essential for normal endothelial function in hypertensive patients to avoid reactive changes in the arterial wall. 45, 46 The community-based Framingham Study with 2883 participants (mean age 61 years) showed that the strongest multivariate correlates of FMD were age, gender and systolic blood pressure. 47 Systolic blood pressure especially seems to be an important correlate of endothelial dysfunction: Each 20 mmHg increment in systolic blood pressure was associated with a 0.62% reduction in FMD. As shown earlier, FMD in drug naive subjects is strongly influenced by systolic blood pressure before carrying out the measurement. 48 Our study failed to show a relation between casual systolic blood pressure and FMD probably because of the variability in blood pressure under anti-hypertensive therapy. The results of our study support the findings that a well-controlled blood pressure during the night protects patients with high blood pressure against organ damage 49 by improving endothelial function, a predictor for cardiovascular events in these patients. 12 In conclusion, IR in patients treated for arterial hypertension is not related to endothelial function and blood pressure regulation. The overall factors influencing endothelial function are nocturnal systolic and diastolic blood pressure.
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